M. Lambers

COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function

H. Hoogsteden, J. Aerts, R. Hendriks, 2010, BMC Cancer.

Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.

H. Hoogsteden, B. Lambrecht, C. Figdor, 2010, American journal of respiratory and critical care medicine.

Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma

M. Nimwegen, H. Hoogsteden, J. Aerts, 2010, British Journal of Cancer.

Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity

H. Hoogsteden, J. Aerts, R. Hendriks, 2010, Journal of biomedicine & biotechnology.

Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.

H. Groen, F. Muskens, H. Hoogsteden, 2013, Lung cancer.

Anti‐inflammatory actions of phosphatidylinositol

E. Kuipers, H. Hammad, B. Lambrecht, 2011, European journal of immunology.

The DNA-binding factor Ctcf critically controls gene expression in macrophages

N. Galjart, R. Hendriks, M. D. Bruijn, 2013, Cellular and Molecular Immunology.

Expression Profiling-Based Subtyping Identifies Novel Non-small Cell Lung Cancer Subgroups and Implicates Putative Resistance to Pemetrexed Therapy

H. Hoogsteden, F. Grosveld, J. Aerts, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Local Immune Regulation of Mucosal Inflammation by Tacrolimus

E. Kuipers, C. J. van der Woude, J. Samsom, 2009, Digestive Diseases and Sciences.